AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Sign up Log in

Tempest Therapeutics, Inc. Director's Dealing 2012

Oct 26, 2012

34632_dirs_2012-10-26_ffc4675d-fd34-4917-a694-63e39e78885e.zip

Director's Dealing

Opens in your device viewer

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: OvaScience, Inc. (OVAS)
CIK: 0001544227
Period of Report: 2012-10-24

Reporting Person: Malley Thomas (Director)

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	31819	Direct